BrainsWay Ltd. announced the expanded market penetration of its Deep Transcranial Magnetic Stimulation (Deep TMSTM) technology in India. After the most recent in a series of successive multisystem orders, Asha Neuromodulation Clinics (ANC) and its affiliates will own 25 Deep TMS systems, substantially increasing access to BrainsWay's patented technology for mental health patients suffering from a range of conditions including depression, obsessive-compulsive disorder (OCD), and smoking addiction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,186 ILa | -1.17% | +18.13% | +3.22% |
06-03 | Brainsway's Deep Transcranial Magnetic Stimulation Gets Expanded FDA Labeling; Shares Rise | MT |
06-03 | BrainsWay Ltd. Receives Expanded FDA Labeling to Treat Late Life Depression | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.22% | 109M | |
+7.32% | 217B | |
+13.83% | 194B | |
+20.48% | 143B | |
+31.33% | 111B | |
+3.08% | 64.3B | |
+14.64% | 52.94B | |
+2.72% | 49.53B | |
-5.88% | 38.31B | |
+0.25% | 35.22B |
- Stock Market
- Equities
- BWAY Stock
- News BrainsWay Ltd.
- BrainsWay Ltd. Accelerates International Expansion in India